Literature DB >> 27911218

Aberrant T cell immunity triggered by human Respiratory Syncytial Virus and human Metapneumovirus infection.

Andrea E González1, Margarita K Lay2, Evelyn L Jara1, Janyra A Espinoza1, Roberto S Gómez1, Jorge Soto1, Claudia A Rivera1, Katia Abarca3, Susan M Bueno1,4, Claudia A Riedel5, Alexis M Kalergis1,3,6.   

Abstract

Human Respiratory syncytial virus (hRSV) and human metapneumovirus (hMPV) are the two major etiological viral agents of lower respiratory tract diseases, affecting mainly infants, young children and the elderly. Although the infection of both viruses trigger an antiviral immune response that mediate viral clearance and disease resolution in immunocompetent individuals, the promotion of long-term immunity appears to be deficient and reinfection are common throughout life. A possible explanation for this phenomenon is that hRSV and hMPV, can induce aberrant T cell responses, which leads to exacerbated lung inflammation and poor T and B cell memory immunity. The modulation of immune response exerted by both viruses include different strategies such as, impairment of immunological synapse mediated by viral proteins or soluble factors, and the induction of pro-inflammatory cytokines by epithelial cells, among others. All these viral strategies contribute to the alteration of the adaptive immunity in order to increase the susceptibility to reinfections. In this review, we discuss current research related to the mechanisms underlying the impairment of T and B cell immune responses induced by hRSV and hMPV infection. In addition, we described the role each virulence factor involved in immune modulation caused by these viruses.

Entities:  

Keywords:  T cells; adaptive immunity; hMPV; hRSV; immunological synapse

Mesh:

Substances:

Year:  2016        PMID: 27911218      PMCID: PMC5626346          DOI: 10.1080/21505594.2016.1265725

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  165 in total

1.  Association of the chimpanzee coryza agent with acute respiratory disease in children.

Authors:  M BEEM; F H WRIGHT; D HAMRE; R EGERER; M OEHME
Journal:  N Engl J Med       Date:  1960-09-15       Impact factor: 91.245

2.  Chimeric recombinant human metapneumoviruses with the nucleoprotein or phosphoprotein open reading frame replaced by that of avian metapneumovirus exhibit improved growth in vitro and attenuation in vivo.

Authors:  Quynh N Pham; Stéphane Biacchesi; Mario H Skiadopoulos; Brian R Murphy; Peter L Collins; Ursula J Buchholz
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

3.  Safety, tolerance and pharmacokinetics of a humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. MEDI-493 Study Group.

Authors:  K N Subramanian; L E Weisman; T Rhodes; R Ariagno; P J Sánchez; J Steichen; L B Givner; T L Jennings; F H Top; D Carlin; E Connor
Journal:  Pediatr Infect Dis J       Date:  1998-02       Impact factor: 2.129

4.  Respiratory syncytial virus G protein and G protein CX3C motif adversely affect CX3CR1+ T cell responses.

Authors:  Jennifer Harcourt; Rene Alvarez; Les P Jones; Christine Henderson; Larry J Anderson; Ralph A Tripp
Journal:  J Immunol       Date:  2006-02-01       Impact factor: 5.422

5.  Function of the respiratory syncytial virus small hydrophobic protein.

Authors:  Sandra Fuentes; Kim C Tran; Priya Luthra; Michael N Teng; Biao He
Journal:  J Virol       Date:  2007-05-09       Impact factor: 5.103

6.  Differential response of human naive and memory/effector T cells to dendritic cells infected by respiratory syncytial virus.

Authors:  T Rothoeft; K Fischer; S Zawatzki; V Schulz; U Schauer; C Körner Rettberg
Journal:  Clin Exp Immunol       Date:  2007-09-24       Impact factor: 4.330

7.  Intranasal administration of antibody-bound respiratory syncytial virus particles efficiently primes virus-specific immune responses in mice.

Authors:  Debby Kruijsen; Helga K Einarsdottir; Marcel A Schijf; Frank E Coenjaerts; Ellen C van der Schoot; Gestur Vidarsson; Grada M van Bleek
Journal:  J Virol       Date:  2013-05-01       Impact factor: 5.103

8.  Respiratory syncytial virus binds and undergoes transcription in neutrophils from the blood and airways of infants with severe bronchiolitis.

Authors:  Clare P Halfhide; Brian F Flanagan; Stephen P Brearey; John A Hunt; Angela M Fonceca; Paul S McNamara; Deborah Howarth; Steven Edwards; Rosalind L Smyth
Journal:  J Infect Dis       Date:  2011-08-01       Impact factor: 5.226

9.  TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand.

Authors:  Tomoki Ito; Yui-Hsi Wang; Omar Duramad; Toshiyuki Hori; Guy J Delespesse; Norihiko Watanabe; F Xiao-Feng Qin; Zhengbin Yao; Wei Cao; Yong-Jun Liu
Journal:  J Exp Med       Date:  2005-11-07       Impact factor: 14.307

Review 10.  Effectiveness of Palivizumab in Preventing RSV Hospitalization in High Risk Children: A Real-World Perspective.

Authors:  Nusrat Homaira; William Rawlinson; Thomas L Snelling; Adam Jaffe
Journal:  Int J Pediatr       Date:  2014-12-04
View more
  7 in total

Review 1.  Prophylactic and therapeutic approaches for human metapneumovirus.

Authors:  Prashant Kumar; Mansi Srivastava
Journal:  Virusdisease       Date:  2018-10-20

2.  Increased Heme Oxygenase 1 Expression upon a Primary Exposure to the Respiratory Syncytial Virus and a Secondary Mycobacterium bovis Infection.

Authors:  Gisela Canedo-Marroquín; Jorge A Soto; Catalina A Andrade; Susan M Bueno; Alexis M Kalergis
Journal:  Antioxidants (Basel)       Date:  2022-07-26

3.  Female offspring gestated in hypothyroxinemia and infected with human Metapneumovirus (hMPV) suffer a more severe infection and have a higher number of activated CD8+ T lymphocytes.

Authors:  Samanta C Funes; Mariana Ríos; Ayleen Fernández-Fierro; Daniela Rivera-Pérez; Jorge A Soto; José R Valbuena; María J Altamirano-Lagos; Felipe Gómez-Santander; Evelyn L Jara; Pablo Zoroquiain; Juan C Roa; Alexis M Kalergis; Claudia A Riedel
Journal:  Front Immunol       Date:  2022-09-08       Impact factor: 8.786

4.  Induction of Protective Immunity by a Single Low Dose of a Master Cell Bank cGMP-rBCG-P Vaccine Against the Human Metapneumovirus in Mice.

Authors:  Jorge A Soto; Nicolás M S Gálvez; Gaspar A Pacheco; Gisela Canedo-Marroquín; Susan M Bueno; Alexis M Kalergis
Journal:  Front Cell Infect Microbiol       Date:  2021-06-29       Impact factor: 5.293

Review 5.  Innate Immune Components that Regulate the Pathogenesis and Resolution of hRSV and hMPV Infections.

Authors:  Catalina A Andrade; Gaspar A Pacheco; Nicolas M S Gálvez; Jorge A Soto; Susan M Bueno; Alexis M Kalergis
Journal:  Viruses       Date:  2020-06-12       Impact factor: 5.048

Review 6.  GM-CSF: Orchestrating the Pulmonary Response to Infection.

Authors:  Thomas S McCormick; Rana B Hejal; Luis O Leal; Mahmoud A Ghannoum
Journal:  Front Pharmacol       Date:  2022-01-17       Impact factor: 5.810

Review 7.  The Role of Nucleoprotein in Immunity to Human Negative-Stranded RNA Viruses-Not Just Another Brick in the Viral Nucleocapsid.

Authors:  Maja Šantak; Zrinka Matić
Journal:  Viruses       Date:  2022-03-03       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.